导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.09% | 887/1050 |
| 近一周 | -3.76% | 953/1104 |
| 近一月 | -11.97% | 1086/1102 |
| 近一季 | -28.47% | 1087/1092 |
| 近半年 | -17.30% | 955/1070 |
| 近一年 | -2.04% | 632/1018 |
| 近两年 | 50.24% | 510/926 |
| 近三年 | 20.30% | 498/833 |
| 成立以来 | 79.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.79% 356/1070 |
19.62% 391/1101 |
- - |
- - |
| 2025 | 64.09% 85/1065 |
-1.01% 859/1014 |
-0.73% 742/1038 |
61.24% 36/1050 |
3.56% 217/1065 |
| 2024 | -7.28% 732/1011 |
2.64% 180/960 |
-6.43% 712/983 |
11.13% 539/991 |
-13.13% 973/1011 |
| 2023 | -38.77% 841/952 |
-10.59% 852/880 |
0.34% 169/895 |
-23.93% 878/915 |
-10.28% 865/952 |
| 2022 | -33.40% 687/867 |
-21.00% 578/773 |
16.95% 72/806 |
-19.37% 738/845 |
-10.60% 799/867 |
| 2021 | 39.75% 36/740 |
15.05% 1/580 |
20.86% 153/659 |
10.09% 60/704 |
-8.71% 649/740 |
| 2020 | 49.15% 239/554 |
-1.21% 193/419 |
19.30% 297/466 |
19.65% 59/517 |
5.78% 424/554 |
| 2019 | 31.80% 280/410 |
2.53% 1078/1149 |
5.66% 37/1231 |
5.77% 187/390 |
15.02% 54/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 摩根核心精选股票A VS. 东吴新产业精选股票A(580008) |